CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Public ClinicalTrials.gov record NCT06783309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-103 in Participants Ages 12-35 With Recent Onset Stage 3 Type 1 Diabetes
Study identification
- NCT ID
- NCT06783309
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- COUR Pharmaceutical Development Company, Inc.
- Industry
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Interventions
- CNP-103 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2025
- Primary completion
- Nov 30, 2026
- Completion
- May 31, 2027
- Last update posted
- May 3, 2026
2025 – 2027
United States locations
- U.S. sites
- 28
- U.S. states
- 15
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wake Research - Tucson | Tucson | Arizona | 85710 | Recruiting |
| Rady Children's Hospital San Diego | San Diego | California | 92123 | Recruiting |
| Diablo Clinical Research | Walnut Creek | California | 94598 | Recruiting |
| Barbara Davis Center for Childhood Diabetes | Aurora | Colorado | 80045 | Recruiting |
| University of Florida | Gainesville | Florida | 32610 | Recruiting |
| University of Miami | Miami | Florida | 33136 | Recruiting |
| DY Professional Research Center | Miami | Florida | 33176 | Recruiting |
| University of South Florida | Tampa | Florida | 33612 | Recruiting |
| Atlanta Diabetes Association | Atlanta | Georgia | 30318 | Recruiting |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | Recruiting |
| Riley Hospital for Children- Indiana University | Indianapolis | Indiana | 46202 | Recruiting |
| Barry J. Reiner, MD, LLC | Baltimore | Maryland | 21229 | Recruiting |
| Joslin Diabetes Center | Boston | Massachusetts | 02215 | Recruiting |
| University of Minnesota | Minneapolis | Minnesota | 55454 | Recruiting |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Recruiting |
| UBMD Pediatrics - University of Buffalo | Buffalo | New York | 14203 | Recruiting |
| MainStreet Health | Syosset | New York | 11791 | Recruiting |
| Duke University | Durham | North Carolina | 27710 | Recruiting |
| Physicians East, PA | Greenville | North Carolina | 27834 | Recruiting |
| Wake Research - Raleigh | Raleigh | North Carolina | 27612 | Recruiting |
| Superior Clinical Research | Smithfield | North Carolina | 27577 | Recruiting |
| Texas Diabetes & Endocrinology | Austin | Texas | 78749 | Recruiting |
| M3 Wake Research - Dallas | Dallas | Texas | 75246 | Recruiting |
| Accurate Clinical Research, Inc | Humble | Texas | 77346 | Recruiting |
| Diabetes & Glandular Disease (DGD) Clinic, P.A. | San Antonio | Texas | 78229 | Recruiting |
| TopLine Clinical, Inc | Waxahachie | Texas | 75165 | Recruiting |
| University of Washington Diabetes Institute | Seattle | Washington | 98109 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06783309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06783309 live on ClinicalTrials.gov.